ANTI-INTERLEUKIN 6 (IL-6) RECEPTOR ANTIBODY SUPPRESSES CASTLEMAN'S DISEASE LIKE SYMPTOMS EMERGED IN IL-6 TRANSGENIC MICE
Authors:
- Asao KatsumeAKAsao Katsume
- Hiroyuki SaitoaHSHiroyuki Saitoa
- Yoshiki YamadaaYYYoshiki Yamadaa
- Keigo YorozuaKYKeigo Yorozua
- Otoya UedaaOUOtoya Uedaa
- Ken- Ichi AkamatsuaKAKen- Ichi Akamatsua
- Norihiro NishimotobNNNorihiro Nishimotob
- Tadamitsu KishimotobTKTadamitsu Kishimotob
- Kazuyuki YoshizakibKYKazuyuki Yoshizakib
- Yoshiyuki OhsugiaYOYoshiyuki Ohsugia
- 1 December 2002
- Vol. 20 (6) , 304-311
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Interleukin-6 in Biology and Medicine1993
- Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice.Journal of Clinical Investigation, 1990
- Interleukin 6 is an autocrine growth factor for mesangial cellsKidney International, 1990
- Increased plasma levels of interleukin-6 in sepsis [see comments]Blood, 1989
- Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's diseaseBlood, 1989
- The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.Journal of Experimental Medicine, 1989
- Excessive production of interleukin 6/B cell stimulatory factor‐2 in rheumatoid arthritisEuropean Journal of Immunology, 1988
- Interleukin‐6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritidesArthritis & Rheumatism, 1988
- Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomasNature, 1988
- Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor.Journal of Experimental Medicine, 1987